Literature DB >> 19595703

The mechanism of life-threatening water imbalance in schizophrenia and its relationship to the underlying psychiatric illness.

Morris B Goldman1.   

Abstract

Impaired water excretion was noted to coincide with psychotic exacerbations in the first decades of the past century. In the ensuing decades, life-threatening water intoxication and elevated plasma levels of the antidiuretic hormone, arginine vasopressin (AVP) were reported in a subset of persons with schizophrenia. Subsequent studies demonstrated that the osmotic set point for AVP secretion was transiently reset in these patients by an unknown process and that this was further exacerbated by acute psychosis. More recent studies indicate that the AVP dysfunction is a manifestation of a hippocampal-mediated impairment in the regulation of both AVP and HPA axis responses to psychological, but not other types of, stimuli. Of potential significance, is that schizophrenic patients without water imbalance exhibit the opposite pattern of responses. Preliminary data indicate those with water imbalance also demonstrate a closely linked deficit in central oxytocin activity which may account for their diminished social function. These latter behavioral deficits are perhaps the most disabling and treatment resistant features of schizophrenia, which recent studies suggest, may respond to oxytocin agonists. Together these findings support the view that schizophrenia is a heterogeneous disorder, and provide novel biomarkers and approaches for exploring the pathophysiology and treatment of severe mental illness.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19595703      PMCID: PMC2757522          DOI: 10.1016/j.brainresrev.2009.06.004

Source DB:  PubMed          Journal:  Brain Res Rev        ISSN: 0165-0173


  95 in total

Review 1.  Dendritic peptide release and peptide-dependent behaviours.

Authors:  Mike Ludwig; Gareth Leng
Journal:  Nat Rev Neurosci       Date:  2006-02       Impact factor: 34.870

2.  A possible role of hippocampal dysfunction in schizophrenic symptomatology.

Authors:  D J Luchins
Journal:  Biol Psychiatry       Date:  1990-07-15       Impact factor: 13.382

3.  Selective impairments in the stress response in schizophrenic patients.

Authors:  L M Jansen; C C Gispen-de Wied; R S Kahn
Journal:  Psychopharmacology (Berl)       Date:  2000-04       Impact factor: 4.530

4.  Mechanisms of altered water metabolism in psychotic patients with polydipsia and hyponatremia.

Authors:  M B Goldman; D J Luchins; G L Robertson
Journal:  N Engl J Med       Date:  1988-02-18       Impact factor: 91.245

5.  Endocrine effects of the cold pressor test: relationships to subjective pain appraisal and coping.

Authors:  M Bullinger; D Naber; D Pickar; R M Cohen; N H Kalin; A Pert; W E Bunney
Journal:  Psychiatry Res       Date:  1984-07       Impact factor: 3.222

6.  Association between stereotypic behavior and polydipsia in chronic schizophrenic patients.

Authors:  M S Shutty; K McCulley; B Pigott
Journal:  J Behav Ther Exp Psychiatry       Date:  1995-12

7.  Validity of a 'proxy' for the deficit syndrome derived from the Positive And Negative Syndrome Scale (PANSS).

Authors:  Raymond R Goetz; Cheryl Corcoran; Scott Yale; Arielle D Stanford; David Kimhy; Xavier Amador; Dolores Malaspina
Journal:  Schizophr Res       Date:  2007-04-12       Impact factor: 4.939

Review 8.  The hypothalamic-neurohypophysial system regulates the hypothalamic-pituitary-adrenal axis under stress: an old concept revisited.

Authors:  Mario Engelmann; Rainer Landgraf; Carsten T Wotjak
Journal:  Front Neuroendocrinol       Date:  2004 Sep-Dec       Impact factor: 8.606

9.  Schizophrenia and the hippocampus: the embryological hypothesis extended.

Authors:  A J Conrad; A B Scheibel
Journal:  Schizophr Bull       Date:  1987       Impact factor: 9.306

10.  Manners of arginine vasopressin secretion in schizophrenic patients--with reference to the mechanism of water intoxication.

Authors:  T Kishimoto; M Hirai; H Ohsawa; M Terada; I Matsuoka; G Ikawa
Journal:  Jpn J Psychiatry Neurol       Date:  1989-06
View more
  23 in total

1.  Structural pathology underlying neuroendocrine dysfunction in schizophrenia.

Authors:  Morris B Goldman; Lei Wang; Carly Wachi; Sheeraz Daudi; John Csernansky; Megan Marlow-O'Connor; Sarah Keedy; Ivan Torres
Journal:  Behav Brain Res       Date:  2010-11-17       Impact factor: 3.332

Review 2.  Obsessive-compulsive disorder: Insights from animal models.

Authors:  Henry Szechtman; Susanne E Ahmari; Richard J Beninger; David Eilam; Brian H Harvey; Henriette Edemann-Callesen; Christine Winter
Journal:  Neurosci Biobehav Rev       Date:  2016-05-07       Impact factor: 8.989

3.  Attributing hyponatraemia to treatment with antipsychotic medications.

Authors:  Richard C Josiassen; Rita A Shaughnessy; Dawn M Filmyer; Brett Audino
Journal:  Drug Saf       Date:  2011-04-01       Impact factor: 5.606

4.  Decrease in Reciprocal Fairness Feeling of Patients with Polydipsic Schizophrenia.

Authors:  Takahiko Nagamine
Journal:  Innov Clin Neurosci       Date:  2016-06-01

Review 5.  Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward.

Authors:  Ellen R Bradley; Joshua D Woolley
Journal:  Neurosci Biobehav Rev       Date:  2017-05-12       Impact factor: 8.989

Review 6.  Postmortem diagnosis of hyponatremia: case report and literature review.

Authors:  Jessica Vanhaebost; Cristian Palmiere; Maria Pia Scarpelli; Fabiola Bou Abdallah; Arnaud Capron; Gregory Schmit
Journal:  Int J Legal Med       Date:  2017-05-13       Impact factor: 2.686

7.  Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders.

Authors:  Leah H Rubin; C Sue Carter; Jeffrey R Bishop; Hossein Pournajafi-Nazarloo; Lauren L Drogos; S Kristian Hill; Anthony C Ruocco; Sarah K Keedy; James L Reilly; Matcheri S Keshavan; Godfrey D Pearlson; Carol A Tamminga; Elliot S Gershon; John A Sweeney
Journal:  Schizophr Bull       Date:  2014-03-11       Impact factor: 9.306

Review 8.  The role of antipsychotics in smoking and smoking cessation.

Authors:  Annette M Matthews; Vanessa B Wilson; Suzanne H Mitchell
Journal:  CNS Drugs       Date:  2011-04       Impact factor: 5.749

Review 9.  Brain circuit dysfunction in a distinct subset of chronic psychotic patients.

Authors:  Morris B Goldman
Journal:  Schizophr Res       Date:  2014-07-01       Impact factor: 4.939

Review 10.  A systematic review of the ability of urine concentration to distinguish antipsychotic- from psychosis-induced hyponatremia.

Authors:  Wanlop Atsariyasing; Morris B Goldman
Journal:  Psychiatry Res       Date:  2014-03-29       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.